Young David 13D and 13G filings for Processa Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-13 10:08 am Purchase |
2020-10-02 | 13D | Processa Pharmaceuticals, Inc. PCSA |
Young David | 99,558 14.200% |
99,558 (New Position) |
Filing |